0 (0%) | 07-26 20:29 | |||||||||||||
|
|
Short term | ![]() ![]() ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 2.07 | 1-year : | 2.42 |
Resists | First : | 1.77 | Second : | 2.07 |
Pivot price | 1.57 ![]() |
|||
Supports | First : | 1.37 ![]() |
Second : | 1.12 ![]() |
MAs | MA(5) : | 1.66 ![]() |
MA(20) : | 1.49 ![]() |
MA(100) : | 0.99 ![]() |
MA(250) : | 1.03 ![]() |
|
MACD | MACD : | 0.1 ![]() |
Signal : | 0.1 ![]() |
%K %D | K(14,3) : | 77.3 ![]() |
D(3) : | 76.1 ![]() |
RSI | RSI(14): 70.5 ![]() |
|||
52-week | High : | 1.77 | Low : | 0.6 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ CLOV ] has closed below upper band by 22.6%. Bollinger Bands are 88.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 1.75 - 1.75 | 1.75 - 1.76 |
Low: | 1.65 - 1.66 | 1.66 - 1.67 |
Close: | 1.72 - 1.73 | 1.73 - 1.74 |
Wed, 24 Jul 2024
Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th - EIN News
Mon, 22 Jul 2024
Clover Health Investments, Corp. (NASDAQ:CLOV) Position Increased by Jupiter Asset Management Ltd. - MarketBeat
Mon, 22 Jul 2024
CLOV - Clover Health Investments, Corp. Latest Stock News & Market Updates - StockTitan
Tue, 16 Jul 2024
Clover Health Investments (NASDAQ:CLOV) Sets New 12-Month High at $1.65 - MarketBeat
Fri, 10 May 2024
Analysts Have Been Trimming Their Clover Health Investments, Corp. (NASDAQ:CLOV) Price Target After Its Latest Report - Yahoo Finance
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 407 (M) |
Shares Float | 393 (M) |
Held by Insiders | 9.1 (%) |
Held by Institutions | 22.5 (%) |
Shares Short | 35,160 (K) |
Shares Short P.Month | 38,080 (K) |
EPS | -0.32 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0.58 |
Profit Margin | -7.8 % |
Operating Margin | -6.6 % |
Return on Assets (ttm) | -7.8 % |
Return on Equity (ttm) | -51 % |
Qtrly Rev. Growth | 7 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 5.06 |
EBITDA (p.s.) | -0.33 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -169 (M) |
Levered Free Cash Flow | 36 (M) |
PE Ratio | -5.41 |
PEG Ratio | -0.4 |
Price to Book value | 2.93 |
Price to Sales | 0.34 |
Price to Cash Flow | -4.17 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |